|
ZNF665 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.37810000000605E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.176950E-03 |
| Normal-vs-Stage2 |
7.143600E-03 |
| Normal-vs-Stage3 |
1.082620E-03 |
| Normal-vs-Stage4 |
3.58290000002093E-06 |
| Stage1-vs-Stage2 |
7.716800E-01 |
| Stage1-vs-Stage3 |
5.258800E-01 |
| Stage1-vs-Stage4 |
4.282100E-03 |
| Stage2-vs-Stage3 |
8.653000E-01 |
| Stage2-vs-Stage4 |
8.022100E-02 |
| Stage3-vs-Stage4 |
6.145800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.825570E-04 |
| Normal-vs-AfricanAmerican |
6.928000E-02 |
| Normal-vs-Asian |
2.569800E-02 |
| Caucasian-vs-AfricanAmerican |
6.687200E-01 |
| Caucasian-vs-Asian |
5.614000E-01 |
| AfricanAmerican-vs-Asian |
9.941800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.836200E-04 |
| Normal-vs-Female |
1.611620E-04 |
| Male-vs-Female |
7.376400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.218900E-03 |
| Normal-vs-Age(41-60Yrs) |
8.037700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.6857999999973E-05 |
| Normal-vs-Age(81-100Yrs) |
1.596600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.455000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.429700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.160000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.047600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.320800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.886000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.974000E-02 |
| Classical-VS-Follicular |
7.250400E-02 |
| Classical-VS-Other |
5.343400E-01 |
| Classical-VS-Normal |
1.597560E-03 |
| Tall-VS-Follicular |
4.956400E-01 |
| Tall-VS-Other |
6.502000E-01 |
| Tall-VS-Normal |
1.244640E-04 |
| Follicular-VS-Other |
9.549800E-01 |
| Follicular-VS-Normal |
4.770200E-04 |
| Other-VS-Normal |
1.134630E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.156600E-04 |
| Normal-vs-N1 |
7.62170000000451E-05 |
| N0-vs-N1 |
1.999230E-01 |
|
|
